gwb | Grubman Warner Berry
False Claims Act

Biotechnology Company Pays $528,335 to Resolve FCA Allegations Over NIH Grant Eligibility

Share This:
Nov 16, 2026

The U.S. Attorney’s Office for the Northern District of California has announced that biotechnology company Cyion Technologies has agreed to pay $528,335.74 to resolve allegations that it violated the False Claims Act (FCA) in connection with three National Institutes of Health (NIH) awards.

The awards included two Small Business Technology Transfer grants and one Small Business Innovation Research grant. According to the government, the applicable grant terms prohibited the principal investigator from maintaining outside full-time employment. The government alleged that Cyion failed to disclose that its principal investigator held outside full-time employment when the company applied for the two grants in 2017 and the third grant in 2023.

The government further alleged that Cyion continued drawing federal funds through 2019 on the earlier awards and through 2024 on the later award without disclosing the outside employment. The investigation was conducted with the Department of Health and Human Services Office of Inspector General (HHS-OIG).

Grant Eligibility Must Be Reconfirmed Through the Drawdown Period

The resolution illustrates that FCA exposure can arise from eligibility representations used to obtain an award and from later drawdowns of federal funds. Principal-investigator employment and effort are not static facts. A change after the application date may affect continued eligibility and can require disclosure before additional funds are requested.

Research companies and other grant recipients should verify principal-investigator employment and effort at application, award, and appropriate intervals during performance. Grants personnel should cross-check certifications against human-resources and outside-employment information, document agency-approved exceptions, and establish a process to suspend drawdowns and evaluate disclosure obligations when an eligibility condition changes.

GWB represents research companies, grant recipients, and other organizations in connection with federal-program compliance, government investigations, and False Claims Act litigation. If you need assistance with such a matter, contact us today.

Get in Touch With Us

For more information or to arrange a consultation, please contact us by telephone at (404) 233-4171 or online by submitting the form below. The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship nor create an expectancy of a potential attorney-client relationship. Do not submit information which is confidential or time sensitive, as it may not be treated as such.